BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jilesen AP, van Eijck CH, in't Hof KH, van Dieren S, Gouma DJ, van Dijkum EJ. Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review. World J Surg 2016;40:729-48. [PMID: 26661846 DOI: 10.1007/s00268-015-3328-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Beger HG. Benign Tumors of the Pancreas—Radical Surgery Versus Parenchyma-Sparing Local Resection—the Challenge Facing Surgeons. J Gastrointest Surg 2018;22:562-6. [DOI: 10.1007/s11605-017-3644-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
2 Billmann F, Nießen A, Hackert T. [Importance of surgery in distant metastatic pancreatic neuroendocrine neoplasms]. Chirurg 2022. [PMID: 35403909 DOI: 10.1007/s00104-022-01630-x] [Reference Citation Analysis]
3 Liu M, Sun X, Zhang Z, Xu X, Yu X, Zhuo Q, Ji S. The clinical characteristics and survival associations of pancreatic neuroendocrine tumors: does age matter? Gland Surg 2021;10:574-83. [PMID: 33708541 DOI: 10.21037/gs-20-634] [Reference Citation Analysis]
4 Giuliani T, Marchegiani G, Girgis MD, Crinò SF, Muthusamy VR, Bernardoni L, Pea A, Ramera M, Paiella S, Landoni L, Gabbrielli A, Salvia R, Donahue TR, Bassi C. Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers. Surg Endosc 2020;34:2796-802. [PMID: 32180000 DOI: 10.1007/s00464-020-07501-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Johnston ME 2nd, Carter MM, Wilson GC, Ahmad SA, Patel SH. Surgical management of primary pancreatic neuroendocrine tumors. J Gastrointest Oncol 2020;11:578-89. [PMID: 32655937 DOI: 10.21037/jgo.2019.12.09] [Reference Citation Analysis]
6 Velez-Serrano JF, Velez-Serrano D, Hernandez-Barrera V, Jimenez-Garcia R, Lopez de Andres A, Garrido PC, Álvaro-Meca A. Prediction of in-hospital mortality after pancreatic resection in pancreatic cancer patients: A boosting approach via a population-based study using health administrative data. PLoS One 2017;12:e0178757. [PMID: 28591154 DOI: 10.1371/journal.pone.0178757] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pavel M, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020;31:844-60. [PMID: 32272208 DOI: 10.1016/j.annonc.2020.03.304] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 43.0] [Reference Citation Analysis]
8 Begum N, Maasberg S, Pascher A, Plöckinger U, Gress TM, Wurst C, Weber F, Raffel A, Krausch M, Holzer K, Bartsch DK, Musholt TJ, Keck T, Anlauf M, Rinke A, Pape UF, Goretzki PE; German NET-Registry. Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia: results from a German nation-wide multi-centric registry. Langenbecks Arch Surg 2020;405:145-54. [PMID: 32372309 DOI: 10.1007/s00423-020-01868-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhang L, Tan S, Huang S, Zhong C, Lü M, Peng Y, Tang X. The safety and efficacy of endoscopic ultrasound-guided ablation therapy for solid pancreatic tumors: a systematic review. Scandinavian Journal of Gastroenterology 2020;55:1121-31. [DOI: 10.1080/00365521.2020.1797870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hofland J, de Herder WW, Kann PH. Turning Up the Heat: Endoscopic Ablation of Pancreatic Neuroendocrine Neoplasms. J Clin Endocrinol Metab 2019;104:5053-5. [PMID: 31058975 DOI: 10.1210/jc.2019-00954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Jeune F, Taibi A, Gaujoux S. Update on the Surgical Treatment of Pancreatic Neuroendocrine Tumors. Scand J Surg. 2020;109:42-52. [PMID: 31975647 DOI: 10.1177/1457496919900417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liu X, Chen K, Chu X, Liu G, Yang Y, Tian X. Prophylactic Intra-Peritoneal Drainage After Pancreatic Resection: An Updated Meta-Analysis. Front Oncol 2021;11:658829. [PMID: 34094952 DOI: 10.3389/fonc.2021.658829] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Heidsma CM, Tsilimigras DI, van Dieren S, Rocha F, Abbott DE, Fields R, Smith PM, Poultsides GA, Cho C, Dillhoff M, Lopez-aguiar AG, Kanji Z, Fisher A, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CH, Nieveen van Dijkum EJ, Maithel SK, Pawlik TM. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors. HPB 2021;23:413-21. [DOI: 10.1016/j.hpb.2020.06.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Salom F, Prat F. Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer. World J Gastrointest Endosc 2022; 14(1): 35-48 [DOI: 10.4253/wjge.v14.i1.35] [Reference Citation Analysis]
15 Uccelli F, Gavazzi F, Capretti G, Virdis M, Montorsi M, Zerbi A. Parenchyma-sparing surgery for pancreatic endocrine tumors. Updates Surg 2016;68:313-9. [DOI: 10.1007/s13304-016-0400-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Partelli S, Cirocchi R, Crippa S, Cardinali L, Fendrich V, Bartsch DK, Falconi M. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg 2017;104:34-41. [PMID: 27706803 DOI: 10.1002/bjs.10312] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 10.8] [Reference Citation Analysis]
17 Sallinen V, Le Large TY, Galeev S, Kovalenko Z, Tieftrunk E, Araujo R, Ceyhan GO, Gaujoux S. Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis. HPB (Oxford). 2017;19:310-320. [PMID: 28254159 DOI: 10.1016/j.hpb.2016.12.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 8.6] [Reference Citation Analysis]
18 Lv Y, Pu N, Mao W, Chen W, Wang H, Han X, Ji Y, Zhang L, Jin D, Lou W, Xu X. Development of predictive prognostic nomogram for NECs of rectum on population-based exploration. Endocr Connect 2018:/journals/ec/aop/ec-18-0353. [PMID: 30352397 DOI: 10.1530/EC-18-0353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Perrier M, Delemer B, Deguelte S, Legros V, Brixi H, Kianmanesh R, Cadiot G. Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient. Pancreatology 2021;21:236-9. [PMID: 33309626 DOI: 10.1016/j.pan.2020.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Assi HA, Mukherjee S, Kunz PL, Machiorlatti M, Vesely S, Pareek V, Hatoum H. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database. Oncologist. 2020;25:e276-e283. [PMID: 32043766 DOI: 10.1634/theoncologist.2019-0466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
21 Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R. Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor. J Visc Surg 2018;155:483-92. [PMID: 30448206 DOI: 10.1016/j.jviscsurg.2018.08.010] [Reference Citation Analysis]
22 Santucci N, Gaujoux S, Binquet C, Reichling C, Lifante JC, Carnaille B, Pattou F, Mirallié E, Facy O, Mathonnet M, Goudet P. Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d'étude des Tumeurs Endocrines) Study. World J Surg 2021;45:1794-802. [PMID: 33649917 DOI: 10.1007/s00268-021-06005-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Albers MB, Almquist M, Bergenfelz A, Nordenström E. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias. Langenbecks Arch Surg 2020;405:137-43. [PMID: 32291468 DOI: 10.1007/s00423-020-01869-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Beger HG, Mayer B. Early postoperative and late metabolic morbidity after pancreatic resections: An old and new challenge for surgeons - A review. Am J Surg 2018;216:131-4. [PMID: 29478825 DOI: 10.1016/j.amjsurg.2018.02.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
25 Barthet M, Giovannini M, Gasmi M, Lesavre N, Boustière C, Napoleon B, LaQuiere A, Koch S, Vanbiervliet G, Gonzalez JM. Long-term outcome after EUS-guided radiofrequency ablation: Prospective results in pancreatic neuroendocrine tumors and pancreatic cystic neoplasms. Endosc Int Open 2021;9:E1178-85. [PMID: 34447860 DOI: 10.1055/a-1479-2199] [Reference Citation Analysis]
26 Wadsworth PK, Jones RP, Poston GJ. Resection of primary gastroenteropancreatic neuroendocrine tumors in the presence of irresectable liver metastases. International Journal of Endocrine Oncology 2016;3:291-7. [DOI: 10.2217/ije-2016-0010] [Reference Citation Analysis]
27 Partelli S, Tamburrino D, Cherif R, Muffatti F, Moggia E, Gaujoux S, Sauvanet A, Falconi M, Fusai G. Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma. Pancreas. 2019;48:504-509. [PMID: 30946244 DOI: 10.1097/mpa.0000000000001273] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
28 Melita G, Pallio S, Tortora A, Crinò SF, Macrì A, Dionigi G. Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms. J Clin Med 2021;10:2638. [PMID: 34203922 DOI: 10.3390/jcm10122638] [Reference Citation Analysis]
29 Larghi A, Rimbaș M, Rizzatti G, Carbone C, Gasbarrini A, Costamagna G, Alfieri S, Tortora G. Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview. Semin Oncol 2021:S0093-7754(21)00004-X. [PMID: 33608132 DOI: 10.1053/j.seminoncol.2021.01.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Sallinen V, Tarvainen T. The Hydrocortisone vs Pasireotide in Reducing Pancreatic Surgery Complications Noninferiority Trial-Reply. JAMA Surg 2020;155:995-6. [PMID: 32667629 DOI: 10.1001/jamasurg.2020.2001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 de Nucci G, Imperatore N, Mandelli ED, di Nuovo F, d'Urbano C, Manes G. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series. Endosc Int Open 2020;8:E1754-8. [PMID: 33269307 DOI: 10.1055/a-1261-9359] [Reference Citation Analysis]
32 Larghi A, Rizzatti G, Rimbaş M, Crino SF, Gasbarrini A, Costamagna G. EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat? Endosc Ultrasound 2019;8:220-6. [PMID: 31249164 DOI: 10.4103/eus.eus_28_19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
33 Tanaka M, Heckler M, Mihaljevic AL, Probst P, Klaiber U, Heger U, Schimmack S, Büchler MW, Hackert T. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 2021;28:1614-24. [PMID: 32720049 DOI: 10.1245/s10434-020-08850-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
34 Imperatore N, de Nucci G, Mandelli ED, de Leone A, Zito FP, Lombardi G, Manes G. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature. Endosc Int Open 2020;8:E1759-64. [PMID: 33269308 DOI: 10.1055/a-1261-9605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Busquets J, Lopez-Dominguez J, Gonzalez-Castillo A, Vila M, Pelaez N, Secanella L, Ramos E, Fabregat J. Pancreas sparing duodenectomy in the treatment of primary duodenal neoplasms and other situations with duodenal involvement. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00039-4. [PMID: 33753002 DOI: 10.1016/j.hbpd.2021.02.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Mackay TM, Genç CG, Takkenberg RB, Besselink MG, Somers I, Nieveen van Dijkum EJM. New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors. J Surg Oncol 2018;117:1548-55. [PMID: 29572825 DOI: 10.1002/jso.25051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Wu W, Jin G, Li H, Miao Y, Wang C, Liang T, Ou J, Zhao Y, Yuan C, Li Y, Lou W, Wu Z, Qin R, Wang H, Hao J, Yu X, Huang H, Tan G, Liu X, Xu K, Wang L, Yang Y, Hao C, Wang W, Guo K, Wei J, Wang Y, Peng C, Wang X, Cai S, Jiang J, Wu X, Yu X, Li F, Zhao Y. The current surgical treatment of pancreatic neuroendocrine neoplasms in China: a national wide cross-sectional study. Journal of Pancreatology 2019;2:35-42. [DOI: 10.1097/jp9.0000000000000019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
38 Partelli S, Bertani E, Bartolomei M, Perali C, Muffatti F, Grana CM, Schiavo Lena M, Doglioni C, Crippa S, Fazio N, Zamboni G, Falconi M. Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms. Surgery. 2018;163:761-767. [PMID: 29284590 DOI: 10.1016/j.surg.2017.11.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
39 Ohta K, Shimohira M, Kawai T, Sawada Y, Nakayama K, Sagoh H, Tatsuta A, Shibamoto Y. Utilization of an Occlusion Balloon Catheter during Stent-Graft Placement to Treat Postsurgical Visceral Arterial Hemorrhage. J Vasc Interv Radiol 2022;33:304-7. [PMID: 35221047 DOI: 10.1016/j.jvir.2021.11.017] [Reference Citation Analysis]
40 Nanashima A, Hiyoshi M, Imamura N, Yano K, Hamada T, Hamada R, Nagatomo K, Ikenoue M, Tobinaga S, Nagayasu T. Clinical significance of preoperative nutritional parameter and patient outcomes after pancreatectomy: A retrospective study at two academic institute.Ann Hepatobiliary Pancreat Surg. 2019;23:168-173. [PMID: 31225419 DOI: 10.14701/ahbps.2019.23.2.168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
41 Constantinescu DP, Constantinescu MI, Ciocan RA, Chiorescu S, Pop MG, Pintea DS, Muntean V. Near infrared light examination as part of the management of sporadic pancreatic head insulinoma: Case report. Int J Surg Case Rep 2019;64:35-40. [PMID: 31593916 DOI: 10.1016/j.ijscr.2019.09.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Tan H, Teo RYA, Syn NL, Teo J, Lee S, Cheow P, Chow PKH, Chung AYF, Ooi LLPJ, Chan C, Goh BKP. Minimally Invasive Versus Open Pancreatectomies for Pancreatic Neuroendocrine Neoplasms: A Propensity-Score-Matched Study. World J Surg 2020;44:3043-51. [DOI: 10.1007/s00268-020-05582-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]